LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 3659 | 10401 | 0.3518 | 0.3181 |
MCF 10A | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 513 | 9497 | 10401 | 0.9131 | 0.9086 |
MCF 10A | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 513 | 11587 | 10401 | 1.1140 | 1.1199 |
MCF 10A | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10462 | 10401 | 1.0059 | 1.0062 |
MCF 10A | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10336 | 10401 | 0.9938 | 0.9935 |
MCF 10A | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 513 | 8988 | 10401 | 0.8641 | 0.8571 |
MCF 10A | Torin1 | 0.04 | uM | LJP6 | 72 | hr | 513 | 2067 | 10401 | 0.1988 | 0.1572 |
MCF 10A | Torin2 | 0.04 | uM | LJP5 | 72 | hr | 513 | 818 | 10401 | 0.0787 | 0.0308 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 513 | 1653 | 10401 | 0.1590 | 0.1153 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 675 | 10401 | 0.0649 | 0.0164 |
MCF 10A | TWS119 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10892 | 10401 | 1.0472 | 1.0497 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10043 | 10401 | 0.9656 | 0.9638 |
MCF 10A | Withaferin A | 0.04 | uM | LJP5 | 72 | hr | 513 | 10161 | 10401 | 0.9770 | 0.9758 |
MCF 10A | Withaferin A | 0.04 | uM | LJP6 | 72 | hr | 513 | 10502 | 10401 | 1.0098 | 1.0103 |
MCF 10A | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 513 | 2567 | 10401 | 0.2468 | 0.2077 |
MCF 10A | WZ3105 | 0.04 | uM | LJP5 | 72 | hr | 513 | 2104 | 10401 | 0.2023 | 0.1609 |
MCF 10A | XMD11-50 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9828 | 10401 | 0.9449 | 0.9421 |
MCF 10A | Y39983 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9617 | 10401 | 0.9246 | 0.9207 |
MCF 10A | YM 201636 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10774 | 10401 | 1.0358 | 1.0377 |
MCF 10A | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 513 | 7992 | 10401 | 0.7684 | 0.7564 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 427 | 10401 | 0.0411 | -0.0087 |
MCF 10A | Sigma A6730 | 0.12 | uM | LJP5 | 72 | hr | 513 | 9681 | 10401 | 0.9308 | 0.9272 |
MCF 10A | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 513 | 486 | 10401 | 0.0468 | -0.0027 |
MCF 10A | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 513 | 7852 | 10401 | 0.7549 | 0.7422 |
MCF 10A | AZD 5438 | 0.12 | uM | LJP6 | 72 | hr | 513 | 5533 | 10401 | 0.5320 | 0.5077 |